Stephen Kent to Bevacizumab
This is a "connection" page, showing publications Stephen Kent has written about Bevacizumab.
Connection Strength
0.043
-
A Non-immunogenic Bivalent d-Protein Potently Inhibits Retinal Vascularization and Tumor Growth. ACS Chem Biol. 2021 03 19; 16(3):548-556.
Score: 0.043
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.